PRAX·Praxis Precision Medicines Inc.
$239.00
-4.34 (-1.78%)
After Hours
High
$245.57
Open
$239.64
Market Cap
6.79B
52W High
$392.70
Low
$236.79
P. Close
$239.00
P/E
-
52W Low
$52.62
Fwd P/E
-26.08
DailyIQ Est.
$741.38
Inst. Ownership
54.3%
Short Interest
15.09%
Days to Cover
7.2
Technical Score (1D)
9
BEARISH
News Sentiment
65
BULLISH
Praxis Precision Medicines Inc. (PRAX) scores 9 on the 1D Technical Score, placing it near the bottom of DailyIQ's momentum ranking: its 12-month price momentum, excluding the latest month, trails most of the stocks we track. The SELL signal and declining momentum reflect that, and the trend bias is bearish. Sentiment at 65 is diverging from the technical read. A low rank describes relative performance, not an oversold condition, so it is not by itself a bounce signal. $261.04 is the first level a recovery would need to clear; $240.96 is the near-term floor.
A bottom momentum rank reflects the prior year of trading, so it changes gradually even when the stock has a strong week. For near-term direction, price levels give the earlier read: a close back above $261.04 on real volume would be the first sign of repair, while a break of $240.96 keeps the bearish trend in charge.
PRAX|Analyst Targets
PRAX|Analyst Targets
LOW TARGET
$188 -21.4%
2 analysts
MEAN TARGET
$644 +169.6%
8 analysts
HIGH TARGET
$1201 +402.5%
16 analysts
PRICE RANGE
$188.00 - $1201.00
SB / B / H / S / SS
9/13/2/1/1
DAILYIQ EST.
$741.38 (+210.2%)
PRAX|Insider Trading
PRAX|Insider Trading
Bought (1Y)
0 shares
$0
Sold (1Y)
11,600 shares
$3.6M
Souza MarcioChief Executive Officer
Souza MarcioChief Executive Officer
DeSimone Jill-
DeSimone Jill-
DeSimone Jill-
PRAX|Fundamentals
PRAX|Fundamentals
Bearish
Overall: Bearish
Revenue declining year over year
Negative operating cash flow
Manageable liabilities relative to assets
Current Ratio
10.22x
Current assets divided by current liabilities: the ability to cover obligations due within a year. Above 1.5x is comfortable, below 1x is a warning sign.
Return on Equity
-34.5%
Net income divided by shareholder equity: how efficiently the company turns equity capital into profit.
PRAX|Earnings Snapshot
PRAX|Earnings Snapshot
EPS
EstBeatMiss
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $-3.63 | - | - |
| Q3'25 | $-3.49 | $-3.36 | +3.7% |
Revenue
EstBeatMiss
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0 | - | - |
| Q3'25 | - | $0 | - |
PRAX|Monthly Returns
PRAX|Monthly Returns
Market Data
PRAX Stock Snapshot
$243.57+$4.57 (1.9%)
- Market cap
- 6.79B
- Day range
- $236.79 – $245.57
- News sentiment
- 65/100 · Bullish
- Analyst target
- $644.42 (+164.6%)
- Consensus
- Buy · 26 analysts
52-week range+362.9% off low · -38.0% from high
$52.62$392.70
Price $243.57 DailyIQ Est. $741.38
Price action on PRAX is defensive - rallies are being sold rather than extended. At this size, a single catalyst moves the stock further than it would a larger peer.
Sector Rotation
Is money rotating into or out of PRAX's sector?
Praxis Precision Medicines Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, PRAX ranks 9th of 15 tracked industries, improving.
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
- Industry rank
- #9 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on PRAX?
HC Wainwright & Co. most recently reiterated its rating on Praxis Precision Medicines Inc. to Buy on Oct 6, 2026 with a price target of $1201. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- HC Wainwright & Co. — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
ETF holders
ETFs holding PRAX
News Sentiment Analysis
Sentiment gathered from recent headlines
65/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
10+ articles
Technical Analysis
Real-time indicators across multiple timeframes
9
BEARISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Institutional & Hedge Fund Ownership
25 tracked managers · $4.94B combined position · 18 adding, 7 trimming, 0 unchanged (latest 13F filings)
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Janus Henderson Group plc | ▲ Buy | 3,458,863 | 12.46% | $1.11B | 2026-05-18 |
| FMR LLC (Fidelity) | ▲ Buy | 2,316,907 | 8.35% | $775.68M | 2026-08-13 |
| BlackRock, Inc. | ▼ Sell | 2,292,585 | 8.26% | $767.53M | 2026-08-07 |
| Vanguard Group Inc | ▲ Buy | 1,460,933 | 5.26% | $430.60M | 2026-01-29 |
| Adage Capital Partners GP, L.L.C. | ▲ Buy | 1,015,480 | 3.66% | $339.97M | 2026-08-14 |
| Morgan Stanley | ▲ Buy | 854,112 | 3.08% | $285.95M | 2026-08-13 |
| Geode Capital Management, LLC | ▲ Buy | 748,039 | 2.69% | $250.48M | 2026-08-12 |
| Goldman Sachs Group Inc | ▼ Sell | 548,830 | 1.98% | $183.74M | 2026-08-14 |
| Bank of America Corp | ▲ Buy | 546,930 | 1.97% | $183.11M | 2026-08-14 |
| Invesco Ltd. | ▲ Buy | 537,548 | 1.94% | $179.97M | 2026-08-14 |
| Norges Bank | ▲ Buy | 346,969 | 1.25% | $116.16M | 2026-08-12 |
| Northern Trust Corp | ▲ Buy | 240,887 | 0.87% | $80.65M | 2026-08-13 |
| Marshall Wace, LLP | ▲ Buy | 137,008 | 0.49% | $45.87M | 2026-08-13 |
| Wellington Management Group LLP | ▼ Sell | 125,867 | 0.45% | $42.14M | 2026-08-14 |
| Neuberger Berman Group LLC | ▲ Buy | 89,468 | 0.32% | $29.95M | 2026-08-13 |
| AllianceBernstein L.P. | ▲ Buy | 71,518 | 0.26% | $23.04M | 2026-08-14 |
| AQR Capital Management LLC | ▼ Sell | 58,446 | 0.21% | $19.57M | 2026-08-14 |
| JPMorgan Chase & Co | ▼ Sell | 44,085 | 0.16% | $15.81M | 2026-08-12 |
| Squarepoint Ops LLC | ▲ Buy | 42,501 | 0.15% | $14.23M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 27,889 | 0.10% | $9.34M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 23,599 | 0.09% | $7.90M | 2026-08-03 |
| Man Group plc | ▲ Buy | 21,164 | 0.08% | $7.09M | 2026-08-14 |
| Prudential Financial Inc | ▼ Sell | 19,541 | 0.07% | $6.54M | 2026-08-12 |
| Two Sigma Investments, LP | ▲ Buy | 18,758 | 0.07% | $6.28M | 2026-08-14 |
| Citadel Advisors LLC | ▼ Sell | 7,331 | 0.03% | $2.45M | 2026-09-02 |
Q2 2026 flow:1.61M sh bought ($538.65M)317.6K sh sold ($107.18M)net +1.29M sh (+$431.47M)
Congressional Trading Activity
2 disclosed trades · ~$16.0K est. traded value · 2 buys, 0 sells
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-09-29 | 2026-10-12 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-07-30 | 2026-09-04 |